Evidence map›Paper›PMID 26984728›Full record

ArticleJournal of virology2016

Mutations in the Schmallenberg Virus Gc Glycoprotein Facilitate Cellular Protein Synthesis Shutoff and Restore Pathogenicity of NSs Deletion Mutants in Mice.

Mariana Varela, Rute Maria Pinto, Marco Caporale, Ilaria M Piras, Aislynn Taggart, Frauke Seehusen, Kerstin Hahn, Anna Janowicz, William Marciel de Souza, Wolfgang Baumgärtner and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
7.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 4 countries.

Mariana VarelaMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland Mariana.varela@glasgow.ac.uk Massimo.palmarini@glasgow.ac.uk.
Rute Maria PintoMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland.
Marco CaporaleMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland.
Ilaria M PirasMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland.
Aislynn TaggartMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland.
Frauke SeehusenDepartment of Pathology and Center of Systems Neuroscience, University of Veterinary Medicine, Hannover, Germany.
Kerstin HahnDepartment of Pathology and Center of Systems Neuroscience, University of Veterinary Medicine, Hannover, Germany.
Anna JanowiczMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland.
William Marciel de SouzaVirology Research Center, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirao Preto, Brazil.
Wolfgang BaumgärtnerDepartment of Pathology and Center of Systems Neuroscience, University of Veterinary Medicine, Hannover, Germany.
Xiaohong ShiMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland.
Massimo PalmariniMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland Mariana.varela@glasgow.ac.uk Massimo.palmarini@glasgow.ac.uk.
MRC University of Glasgow Centre for Virus Research · GBUniversity of Veterinary Medicine Hannover, Foundation · DEUniversidade de São Paulo · BR

Funding

Medical Research Council MC_UU_12014/10Wellcome Trust
6 · The paper itself

Abstract

unlabelledSerial passage of viruses in cell culture has been traditionally used to attenuate virulence and identify determinants of viral pathogenesis. In a previous study, we found that a strain of Schmallenberg virus (SBV) serially passaged in tissue culture (termed SBVp32) unexpectedly displayed increased pathogenicity in suckling mice compared to wild-type SBV. In this study, we mapped the determinants of SBVp32 virulence to the viral genome M segment. SBVp32 virulence is associated with the capacity of this virus to reach high titers in the brains of experimentally infected suckling mice. We also found that the Gc glycoprotein, encoded by the M segment of SBVp32, facilitates host cell protein shutoff in vitro Interestingly, while the M segment of SBVp32 is a virulence factor, we found that the S segment of the same virus confers by itself an attenuated phenotype to wild-type SBV, as it has lost the ability to block the innate immune system of the host. Single mutations present in the Gc glycoprotein of SBVp32 are sufficient to compensate for both the attenuated phenotype of the SBVp32 S segment and the attenuated phenotype of NSs deletion mutants. Our data also indicate that the SBVp32 M segment does not act as an interferon (IFN) antagonist. Therefore, SBV mutants can retain pathogenicity even when they are unable to fully control the production of IFN by infected cells. Overall, this study suggests that the viral glycoprotein of orthobunyaviruses can compensate, at least in part, for the function of NSs. In addition, we also provide evidence that the induction of total cellular protein shutoff by SBV is determined by multiple viral proteins, while the ability to control the production of IFN maps to the NSs protein. IMPORTANCE: The identification of viral determinants of pathogenesis is key to the development of prophylactic and intervention measures. In this study, we found that the bunyavirus Gc glycoprotein is a virulence factor. Importantly, we show that mutations in the Gc glycoprotein can restore the pathogenicity of attenuated mutants resulting from deletions or mutations in the nonstructural protein NSs. Our findings highlight the fact that careful consideration should be taken when designing live attenuated vaccines based on deletions of nonstructural proteins since single mutations in the viral glycoproteins appear to revert attenuated mutants to virulent phenotypes.

Indexed as

MutationProtein BiosynthesisAnimalsBrainBunyaviridae InfectionsCell LineGenome, ViralGlycoproteinsHost-Pathogen InteractionsInterferonsMiceOrthobunyavirusSequence DeletionViral LoadViral Nonstructural ProteinsViral ProteinsGlycoproteinsInterferonsViral Nonstructural ProteinsViral ProteinsVirulence Factors

Identifiers

PMID26984728
PMCPMC4934738
OpenAlexW2300503793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.